{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:39:50Z","timestamp":1792571990193,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shaanxi Province Key Research and Development Project","award":["2025SF-YBXM-301"],"award-info":[{"award-number":["2025SF-YBXM-301"]}]},{"name":"Innovation Capacity Support Program of Shaanxi Province","award":["2022-XKCRC-03"],"award-info":[{"award-number":["2022-XKCRC-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05749-x","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:55:44Z","timestamp":1790589344000},"page":"5679-5695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ANKRD28 interacts with DOCK180 to activate Rac1-STAT3-Myc signaling and sustain stemness of CD34+ leukemia stem cells in acute myeloid leukemia"],"prefix":"10.1007","volume":"481","author":[{"given":"Xiaoyan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huachao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"5749_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM (2025) Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management. Am J Hematol 100:860\u2013891","journal-title":"Am J Hematol"},{"key":"5749_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115709","volume":"215","author":"AK Abdel-Aziz","year":"2023","unstructured":"Abdel-Aziz AK (2023) Advances in acute myeloid leukemia differentiation therapy: a critical review. Biochem Pharmacol 215:115709","journal-title":"Biochem Pharmacol"},{"key":"5749_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/jpm16030169","volume":"16","author":"KH Ko","year":"2026","unstructured":"Ko KH, Gelfer R, Wheat JC, Cai SF (2026) Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions. J Pers Med 16:169","journal-title":"J Pers Med"},{"key":"5749_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2025.102604","volume":"87","author":"MP Connor","year":"2026","unstructured":"Connor MP, Barsouk A, Elghawy O, Lai C (2026) Advancements in targeted therapies for acute myeloid leukemia. Curr Opin Pharmacol 87:102604","journal-title":"Curr Opin Pharmacol"},{"key":"5749_CR5","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1182\/bloodadvances.2025015797","volume":"9","author":"NG van der Maas","year":"2025","unstructured":"van der Maas NG, Breems D, Klerk CPW, Pabst T (2025) A revised prognostic model for patients with acute myeloid leukemia and first relapse. Blood Adv 9:3853\u20133864","journal-title":"Blood Adv"},{"key":"5749_CR6","doi-asserted-by":"publisher","first-page":"10800","DOI":"10.1038\/s41467-025-65842-5","volume":"16","author":"M Zhu","year":"2025","unstructured":"Zhu M, Yang H (2025) Targeting leukemic stem cell biomechanics suppresses stemness and enhances NK cell-mediated immunotherapy. Nat Commun 16:10800","journal-title":"Nat Commun"},{"key":"5749_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A (2023) Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108:353\u2013366","journal-title":"Haematologica"},{"key":"5749_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s12015-021-10308-6","volume":"18","author":"NA Long","year":"2022","unstructured":"Long NA, Golla U, Sharma A, Claxton DF (2022) Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications. Stem Cell Rev Rep 18:1211\u20131226","journal-title":"Stem Cell Rev Rep"},{"key":"5749_CR9","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101346","volume":"5","author":"KJ Han","year":"2022","unstructured":"Han KJ, Mikalayeva V (2022) Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. Life Sci Alliance 5:e202101346","journal-title":"Life Sci Alliance"},{"key":"5749_CR10","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1111\/cas.16271","volume":"115","author":"N Fujiwara","year":"2024","unstructured":"Fujiwara N, Tsunedomi R, Kimura Y, Nakajima M, Tomochika S, Enjoji S et al (2024) Protein phosphatase 6 promotes stemness of colorectal cancer cells. Cancer Sci 115:3067\u20133078","journal-title":"Cancer Sci"},{"key":"5749_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.yexcr.2008.12.005","volume":"315","author":"M Tachibana","year":"2009","unstructured":"Tachibana M, Kiyokawa E, Hara S, Iemura SI, Natsume T, Manabe T et al (2009) Ankyrin repeat domain 28 (ANKRD28), a novel binding partner of DOCK180, promotes cell migration by regulating focal adhesion formation. Exp Cell Res 315:863\u2013876","journal-title":"Exp Cell Res"},{"key":"5749_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1532\/IJH97.07054","volume":"86","author":"M Ishikawa","year":"2007","unstructured":"Ishikawa M, Yagasaki F, Okamura D, Maeda T, Sugahara Y, Jinnai I et al (2007) A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11)(p25;q35;p15) in an adult patient with myelodysplastic syndrome\/acute myelogenous leukemia. Int J Hematol 86:238\u2013245","journal-title":"Int J Hematol"},{"key":"5749_CR13","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/leu.2011.172","volume":"25","author":"HJ de Jonge","year":"2011","unstructured":"de Jonge HJ, Woolthuis CM, Vos AZ, Mulder A, van den Berg E, Kluin PM et al (2011) Gene expression profiling in the leukemic stem cell-enriched CD34\u2009+\u2009fraction identifies target genes that predict prognosis in normal karyotype AML. Leukemia 25:1825\u20131833","journal-title":"Leukemia"},{"key":"5749_CR14","doi-asserted-by":"publisher","first-page":"e2415695","DOI":"10.1002\/advs.202415695","volume":"12","author":"B Chen","year":"2025","unstructured":"Chen B, Liu J (2025) Enhancer Extrachromosomal Circular DNA ANKRD28 Elicits Drug Resistance via POU2F2-Mediated Transcriptional Network in Multiple Myeloma. Adv Sci (Weinh) 12:e2415695","journal-title":"Adv Sci (Weinh)"},{"key":"5749_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1182\/blood.2021013201","volume":"139","author":"ML Amaya","year":"2022","unstructured":"Amaya ML, Inguva A, Pei S, Jones C, Krug A, Ye H et al (2022) The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation. Blood 139:584\u2013596","journal-title":"Blood"},{"key":"5749_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105768","volume":"96","author":"CJ Teng","year":"2024","unstructured":"Teng CJ, Cheng PT, Cheng YC, Tsai JR, Chen MC, Lin H (2024) Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1\/STAT3\/MYC pathways. Toxicol In Vitro 96:105768","journal-title":"Toxicol In Vitro"},{"key":"5749_CR17","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1038\/emm.2016.17","volume":"48","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Yoon S (2016) Activated Rac1 regulates the degradation of I\u03baB\u03b1 and the nuclear translocation of STAT3-NF\u03baB complexes in starved cancer cells. Exp Mol Med 48:e231","journal-title":"Exp Mol Med"},{"key":"5749_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41374-018-0071-2","volume":"98","author":"K Zhou","year":"2018","unstructured":"Zhou K, Rao J (2018) RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3. Lab Invest 98:989\u2013998","journal-title":"Lab Invest"},{"key":"5749_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep23972","volume":"6","author":"L Zhao","year":"2016","unstructured":"Zhao L, Du X, Huang K, Zhang T, Teng Z, Niu W et al (2016) Rac1 modulates the formation of primordial follicles by facilitating STAT3-directed Jagged1, GDF9 and BMP15 transcription in mice. Sci Rep 6:23972","journal-title":"Sci Rep"},{"key":"5749_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.yexcr.2009.10.017","volume":"316","author":"R Arulanandam","year":"2010","unstructured":"Arulanandam R, Geletu M, Feracci H, Raptis L (2010) Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration. Exp Cell Res 316:875\u2013886","journal-title":"Exp Cell Res"},{"key":"5749_CR21","doi-asserted-by":"publisher","first-page":"15397","DOI":"10.1074\/jbc.RA118.003063","volume":"293","author":"W Li","year":"2018","unstructured":"Li W, Xiong X, Abdalla A, Alejo S, Zhu L, Lu F (2018) HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion. J Biol Chem 293:15397\u201315418","journal-title":"J Biol Chem"},{"key":"5749_CR22","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1158\/1541-7786.MCR-16-0318","volume":"15","author":"SA Misek","year":"2017","unstructured":"Misek SA, Chen J, Schroeder L, Rattanasinchai C, Sample A, Sarkaria JN et al (2017) EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion. Mol Cancer Res 15:1085\u20131095","journal-title":"Mol Cancer Res"},{"key":"5749_CR23","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1038\/s41375-024-02358-9","volume":"38","author":"H Boutzen","year":"2024","unstructured":"Boutzen H, Murison A, Oriecuia A, Bansal S, Arlidge C, Wang JCY et al (2024) Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties. Leukemia 38:2090\u20132101","journal-title":"Leukemia"},{"key":"5749_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.32604\/biocell.2021.014139","volume":"46","author":"Q Tao","year":"2021","unstructured":"Tao Q, Zhang Q, Wang H, Xiao HAO, Zhou MEI, Liu L et al (2021) CD34\u2009+\u2009CD38- subpopulation without CD123 and CD44 is responsible for LSC and correlated with imbalance of immune cell subsets in AML. Biocell 46:159\u2013169","journal-title":"Biocell"},{"key":"5749_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/CCO.0000000000001094","volume":"36","author":"S Travaglini","year":"2024","unstructured":"Travaglini S, Gurnari C, Ottone T, Voso MT (2024) Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments. Curr Opin Oncol 36:569\u2013576","journal-title":"Curr Opin Oncol"},{"key":"5749_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12943-025-02455-y","volume":"24","author":"F Lo Schiavo","year":"2025","unstructured":"Lo Schiavo F, Salvesi C, Jandoubi M, Pirini F, Garbetta J, Martinelli G et al (2025) Novel molecular mechanisms of FLT3 deregulation: from the acute myeloid leukemia experience to therapeutic insights in acute lymphoblastic leukemia. Mol Cancer 24:266","journal-title":"Mol Cancer"},{"key":"5749_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13045-020-00992-1","volume":"13","author":"MT Gebru","year":"2020","unstructured":"Gebru MT, Wang HG (2020) Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia. J Hematol Oncol 13:155","journal-title":"J Hematol Oncol"},{"key":"5749_CR28","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1182\/bloodadvances.2020001742","volume":"4","author":"H Herrmann","year":"2020","unstructured":"Herrmann H, Sadovnik I, Eisenwort G, R\u00fclicke T, Blatt K, Herndlhofer S et al (2020) Delineation of target expression profiles in CD34+\/CD38- and CD34+\/CD38\u2009+\u2009stem and progenitor cells in AML and CML. Blood Adv 4:5118\u20135132","journal-title":"Blood Adv"},{"key":"5749_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41375-023-01811-5","volume":"37","author":"MF van Spronsen","year":"2023","unstructured":"van Spronsen MF, Hanekamp D, Westers TM, van Gils N, Vermue E, Rutten A et al (2023) Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression. Leukemia 37:680\u2013690","journal-title":"Leukemia"},{"key":"5749_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/stem.3373","volume":"39","author":"M Pagin","year":"2021","unstructured":"Pagin M, Pernebrink M, Giubbolini S, Barone C, Sambruni G, Zhu Y et al (2021) Sox2 controls neural stem cell self-renewal through a Fos-centered gene regulatory network. Stem Cells 39:1107\u20131119","journal-title":"Stem Cells"},{"key":"5749_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3389\/fphar.2018.00687","volume":"9","author":"DD Xu","year":"2018","unstructured":"Xu DD, Wang Y, Zhou PJ, Qin SR, Zhang R, Zhang Y et al (2018) The IGF2\/IGF1R\/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells. Front Pharmacol 9:687","journal-title":"Front Pharmacol"},{"key":"5749_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1535370220905560","volume":"245","author":"G Grubelnik","year":"2020","unstructured":"Grubelnik G, Bo\u0161tjan\u010di\u010d E, Pavli\u010d A, Kos M (2020) Nanog expression in human development and cancerogenesis. Exp Biol Med 245:456\u2013464","journal-title":"Exp Biol Med"},{"key":"5749_CR33","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s12015-021-10253-4","volume":"17","author":"H Yu","year":"2021","unstructured":"Yu H, Gao R, Chen S, Liu X, Wang Q, Cai W et al (2021) Bmi1 Regulates Wnt Signaling in Hematopoietic Stem and Progenitor Cells. Stem Cell Rev Rep 17:2304\u20132313","journal-title":"Stem Cell Rev Rep"},{"key":"5749_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00018-025-05701-0","volume":"82","author":"EJ Lee","year":"2025","unstructured":"Lee EJ, Sun R, Kim J (2025) The self-renewal function of Oct-4 can be replaced by the EWS-Oct-4 fusion protein in embryonic stem cells. Cell Mol Life Sci 82:166","journal-title":"Cell Mol Life Sci"},{"key":"5749_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41389-025-00553-6","volume":"14","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Li Z, Zhao P, Guan Y, Chu H, Xi Y (2025) FLT3 inhibition upregulates OCT4\/NANOG to promote maintenance and TKI resistance of FLT3-ITD(+) acute myeloid leukemia. Oncogenesis 14:7","journal-title":"Oncogenesis"},{"key":"5749_CR36","doi-asserted-by":"publisher","first-page":"e2404476","DOI":"10.1002\/advs.202404476","volume":"11","author":"J Li","year":"2024","unstructured":"Li J, Wang Y, Wang Z, Wei Y, Diao P, Wu Y et al (2024) Super-Enhancer Driven LIF\/LIFR-STAT3-SOX2 Regulatory Feedback Loop Promotes Cancer Stemness in Head and Neck Squamous Cell Carcinoma. Adv Sci (Weinh) 11:e2404476","journal-title":"Adv Sci (Weinh)"},{"key":"5749_CR37","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-18-2847","volume":"79","author":"B Das","year":"2019","unstructured":"Das B, Pal B, Bhuyan R, Li H, Sarma A, Gayan S et al (2019) MYC Regulates the HIF2\u03b1 Stemness Pathway via Nanog and Sox2 to Maintain Self-Renewal in Cancer Stem Cells versus Non-Stem Cancer Cells. Cancer Res 79:4015\u20134025","journal-title":"Cancer Res"},{"key":"5749_CR38","doi-asserted-by":"publisher","first-page":"928328","DOI":"10.3389\/fgene.2022.928328","volume":"13","author":"N Ye","year":"2022","unstructured":"Ye N, Cai J, Dong Y, Chen H, Bo Z, Zhao X et al (2022) A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery. Front Genet 13:928328","journal-title":"Front Genet"},{"key":"5749_CR39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jclinpath-2020-206927","volume":"74","author":"MA Al Barashdi","year":"2021","unstructured":"Al Barashdi MA, Ali A, McMullin MF (2021) Protein tyrosine phosphatase receptor type C (PTPRC or CD45). J Clin Pathol 74:548\u2013552","journal-title":"J Clin Pathol"},{"key":"5749_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101485","volume":"5","author":"CG Hollands","year":"2024","unstructured":"Hollands CG, Boyd AL, Zhao X, Reid JC, Henly C, ElRafie A et al (2024) Identification of cells of leukemic stem cell origin with non-canonical regenerative properties. Cell Rep Med 5:101485","journal-title":"Cell Rep Med"},{"key":"5749_CR41","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/IGC.0000000000000137","volume":"24","author":"J Wang","year":"2014","unstructured":"Wang J, Dai JM, Che YL, Gao YM, Peng HJ, Liu B et al (2014) Elmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancer. Int J Gynecol Cancer 24:844\u2013850","journal-title":"Int J Gynecol Cancer"},{"key":"5749_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113453","volume":"423","author":"G Liu","year":"2023","unstructured":"Liu G, Xia Y, Wang H, Jin X, Chen S, Chen W et al (2023) Downregulation of CYRI-B promotes migration, invasion and EMT by activating the Rac1-STAT3 pathway in gastric cancer. Exp Cell Res 423:113453","journal-title":"Exp Cell Res"},{"key":"5749_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101876","volume":"40","author":"AL Hemsing","year":"2024","unstructured":"Hemsing AL, F\u00f8rde JL, Reikvam H, Herfindal L (2024) The Rac1-inhibitor EHop-016 attenuates AML cell migration and enhances the efficacy of daunorubicin in MOLM-13 transplanted zebrafish larvae. Transl Oncol 40:101876","journal-title":"Transl Oncol"},{"key":"5749_CR44","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/biomedicines9081051","volume":"9","author":"B Moser","year":"2021","unstructured":"Moser B, Edtmayer S (2021) The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia. Biomedicines 9:1051","journal-title":"Biomedicines"},{"key":"5749_CR45","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3324\/haematol.2023.282691","volume":"109","author":"M Li","year":"2024","unstructured":"Li M, Wu X, Chen M, Hao S, Yu Y, Li X et al (2024) DNAJC10 maintains survival and self-renewal of leukemia stem cells through PERK branch of the unfolded protein response. Haematologica 109:751\u2013764","journal-title":"Haematologica"},{"key":"5749_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.stem.2022.12.003","volume":"30","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Gao Z, Zhang T, Wang Y, Xie X, Han G et al (2023) Decoding m(6)A RNA methylome identifies PRMT6-regulated lipid transport promoting AML stem cell maintenance. Cell Stem Cell 30:69\u201385","journal-title":"Cell Stem Cell"},{"key":"5749_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217158","volume":"600","author":"YQ Wang","year":"2024","unstructured":"Wang YQ, Ren Y, Gale RP, Niu LT, Huang XJ (2024) Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells. Cancer Lett 600:217158","journal-title":"Cancer Lett"},{"key":"5749_CR48","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41375-026-02883-9","volume":"40","author":"S Chakraborty","year":"2026","unstructured":"Chakraborty S, Morganti C, Zaldana K (2026) A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia. Leukemia 40:717\u2013729","journal-title":"Leukemia"},{"key":"5749_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081881","volume":"10","author":"AL Hemsing","year":"2022","unstructured":"Hemsing AL, Rye KP, Hatfield KJ (2022) NPM1-mutated patient-derived AML cells are more vulnerable to Rac1 inhibition. Biomedicines 10:1881","journal-title":"Biomedicines"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05749-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:55:37Z","timestamp":1792569337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5749"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05749-x","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human primary AML samples were approved by the Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University (approval No. X-XJTU1AF2025LSY-386). Written informed consent was obtained from all enrolled patients in accordance with the Declaration of Helsinki. All animal experiments were performed following protocols approved by the Animal Care and Use Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University and complied with the ARRIVE guidelines.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}